Amir Mayer
Internal Medicine · Brooklyn, NYNPI 1043386915
Payments from drug & device makers
Across 53 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$265
- Biohaven Pharmaceuticals, Inc.$143
- Boehringer Ingelheim$122
- Lilly USA, LLC$119
- Astellas Pharma US Inc$97
- AstraZeneca$61
- plus $428 from 16 others
What the payments were for
- Food & beverage$1,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $265 |
| Biohaven Pharmaceuticals, Inc. | 2 | $143 |
| Boehringer Ingelheim | 6 | $122 |
| Lilly USA, LLC | 7 | $119 |
| Astellas Pharma US Inc | 5 | $97 |
| AstraZeneca | 3 | $61 |
| Amneal Pharmaceuticals LLC | 3 | $54 |
| Pfizer | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Vertex | 1 | $30 |
| GRT US Holding, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Renalytix AI, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Exact Sciences | 1 | $16 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$150
- NURTEC ODT$125
How this compares
$1,235 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 108 | $111,898 |
| JardianceEmpagliflozin | 112 | $107,460 |
| LinzessLinaclotide | 97 | $59,616 |
| OzempicSemaglutide | 63 | $59,474 |
| EliquisApixaban | 54 | $53,028 |
| TrulicityDulaglutide | 30 | $42,103 |
| ProliaDenosumab | 26 | $41,218 |
| Imatinib Mesylate | 18 | $39,356 |
| FarxigaDapagliflozin Propanediol | 40 | $32,751 |
| MyrbetriqMirabegron | 49 | $28,962 |
| JanumetSitagliptin Phos/Metformin Hcl | 24 | $26,817 |
| JanuviaSitagliptin Phosphate | 24 | $24,484 |
| RybelsusSemaglutide | 24 | $23,250 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 28 | $20,492 |
| XareltoRivaroxaban | 20 | $18,808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Jentadueto, Synjardy | $122 | $158,879185 claims |
| Lilly USA, LLCMounjaro, Trulicity | $119 | $154,001138 claims |
| AbbVieLinzess, Synthroid | $15 | $61,782124 claims |
| PfizerEliquis | $48 | $53,02854 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $61 | $48,81857 claims |
| AmgenProlia | $265 | $41,21826 claims |
| Astellas Pharma US IncMyrbetriq | $97 | $28,96249 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $54 | $1,445148 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.